Cas12 Protein Market Report 2026

Cas12 Protein Market Overview

• Cas12 Protein market size has reached to $2.26 billion in 2025 • Expected to grow to $4.65 billion in 2030 at a compound annual growth rate (CAGR) of 15.4% • Growth Driver: Rising Genetic Disease Prevalence Drives Growth In The Market Due To Increasing Consanguineous Marriages And Advances In Gene Editing • Market Trend: Advancements In Strategic Equity Investments Driving Advancements In Next-Generation Gene Editing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cas12 Protein Market?

Cas12 protein is a clustered regularly interspaced short palindromic repeats (CRISPR)-associated enzyme that plays a key role in gene editing and molecular diagnostics. CRISPR RNA guides Cas12 to find specific DNA sequences and cut them accurately, enabling targeted genetic changes. It also has collateral cleavage activity, which makes it useful for quick and sensitive diagnostic tests. The main types of Cas12 protein are natural Cas12 proteins, modified Cas12 proteins, and integration with other CRISPR components. Natural Cas12 proteins are bacterial enzymes that recognize and cleave specific DNA sequences as part of the CRISPR immune defense system. These proteins are available in various formulations, such as liquid, lyophilized powder, and plasmid-derived forms, and Common delivery methods include viral vectors, lipid nanoparticles, electroporation, and microinjection. These are widely used for applications including genome editing, gene knockout, gene regulation, genetic engineering, and therapeutic development, and they serve end users such as academic and research institutions, pharmaceutical and biotech companies, diagnostic labs, and agricultural organizations.

What Is The Cas12 Protein Market Growth Forecast?

The cas12 protein market size is expected to see rapid growth in the next few years. It will grow to $4.65 billion in 2030 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to expansion of crispr-based diagnostics, development of advanced delivery methods, increasing investment in gene therapies, growing pharmaceutical and biotechnology r&d spending, rising regulatory approvals for crispr-based therapeutics. Major trends in the forecast period include growing use of cas12 in rapid molecular diagnostics, rising adoption of cas12 for precise genome editing, increasing development of modified and high-fidelity cas12 variants, expansion of cas12 applications in therapeutics development, rising demand for lyophilized and stable cas12 formulations.

Global Cas12 Protein Market Segmentation

1) By Type: Natural Cas12 Proteins, Modified Cas12 Proteins, Integration With Other CRISPR Components 2) By Formulation: Liquid Formulations, Lyophilized Powder, Plasmid-Derived Cas12 Proteins 3) By Delivery Method: Viral Vectors, Lipid Nanoparticles, Electroporation, Microinjection 4) By Application: Genome Editing, Gene Knockout, Gene Regulation, Genetic Engineering, Therapeutics Development 5) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Agricultural Companies Subsegments: 1) By Natural Cas12 Proteins: Cas12a, Cas12b, Cas12c 2) By Modified Cas12 Proteins: Engineered Cas12 Variants, High-Fidelity Cas12 Proteins, Fusion Proteins With Cas12 3) By Integration With Other CRISPR Components: Cas12 With Cas9 Systems, Cas12 With Base Editors, Cas12 With Prime Editors

What Is The Driver Of The Cas12 Protein Market?

The increasing prevalence of genetic diseases is expected to propel the growth of the Cas12 protein market going forward. Genetic diseases are disorders caused by changes or mutations in an individual's DNA that affect normal body functions. The increasing genetic diseases are due to the rising rate of consanguineous marriages, which increases the likelihood of inheriting genetic disorders. Cas12 protein targets and cuts DNA at specific sites to correct, remove, or replace faulty genes, enabling precise gene therapies for inherited disorders with high accuracy and minimal off-target effects. For instance, in July 2025, according to the National Blood Authority, an Australia-based blood management agency, there were 2,788 patients living with hereditary haemophilia A (HMA) in 2023–2024, up from 2,681 patients in 2022–2023. Therefore, the increasing prevalence of genetic diseases is driving the growth of the Cas12 protein industry.

Key Players In The Global Cas12 Protein Market

Major companies operating in the cas12 protein market are Thermo Fisher Scientific Inc., Bio-Techne Corporation, Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Aldevron LLC, New England Biolabs Inc., Synthego Corporation, Mammoth Biosciences Inc., Editas Medicine Inc., VectorBuilder, Sherlock Biosciences, Inscripta Inc.

Global Cas12 Protein Market Trends and Insights

Major companies operating in the Cas12 protein market are focusing on developing advanced solutions, such as equity investment, to accelerate innovation and expand their gene-editing capabilities. Equity investment refers to the process of investing money by purchasing shares or ownership stakes in a company, giving the investor partial ownership and potential returns based on the company’s performance. For instance, in April 2024, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, invested $100 million in Mammoth Biosciences to access their ultracompact CRISPR enzymes for delivering in vivo gene editing therapies using adeno-associated viruses (AAVs) to multiple tissues beyond the liver. These companies combine Mammoth’s ultracompact CRISPR enzymes with its advanced AAV delivery system for targeted gene therapies beyond the liver. These smaller enzymes fit within AAV vectors, enabling precise and efficient in vivo editing. The partnership offers Mammoth major funding, milestones, and royalties, while Regeneron gains exclusive access to cutting-edge tools for over five years. Together, they aim to accelerate next-generation genetic medicines for a wider range of diseases.

What Are Latest Mergers And Acquisitions In The Cas12 Protein Market?

In August 2023, Hui-Gene Therapeutics Co., Ltd., a China-based biotechnology company, partnered with Kactus Biotechnology to develop innovative gene-editing therapies targeting rare genetic disorders. This partnership aims to accelerate the commercialization and GMP manufacturing of HuidaGene's high-precision gene editing enzyme hfCas12Max in Greater China, utilizing Kactus Bio's expertise to advance next-generation genome medicines. Kactus Biotechnology is a China-based biotechnology company that manufactures Cas12 proteins.

Regional Insights

North America was the largest region in the Cas12 protein market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cas12 Protein Market?

The Cas12 protein market consists of sales of molecular diagnostic kits, research reagents, and biosensors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cas12 Protein Market Report 2026?

The cas12 protein market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cas12 protein industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.